Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,756 Cr
up ₹276 Cr vs Jun 2024
- Stocks held
- 29
- up 2 vs Jun 2024
- Top 10 weight
- 68.2%
- of the portfolio in its ten largest
- Cash & debt
- 3.3%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 2
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2024 it disclosed 29 stocks worth ₹2,756 Cr, up ₹276 Cr from Jun 2024. Its largest positions were Sun Pharmaceutical Industries Limited (11.7%), Suven Pharmaceuticals Limited (10.5%), Cipla Limited (7.8%); the ten largest together made up 68.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 69.7% of its equity. Cash and debt stood at 3.3%. Compared with Jun 2024 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
51%
Holds more cash than 51% of peers
Holdings in July 2024
Download CSVEvery line the fund disclosed, with the change against Jun 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 11.70%
- Δ weight
- down 0.80 pts
- Value
- ₹322 Cr
- Δ value
- up ₹12.6 Cr
- Status
- Added
- Weight
- 10.47%
- Δ weight
- up 1.09 pts
- Value
- ₹289 Cr
- Δ value
- up ₹55.9 Cr
- Status
- Added
- Weight
- 7.77%
- Δ weight
- down 0.51 pts
- Value
- ₹214 Cr
- Δ value
- up ₹8.8 Cr
- Status
- Added
- Weight
- 7.61%
- Δ weight
- up 0.30 pts
- Value
- ₹210 Cr
- Δ value
- up ₹28.6 Cr
- Status
- Added
- Weight
- 7.58%
- Δ weight
- up 0.43 pts
- Value
- ₹209 Cr
- Δ value
- up ₹31.7 Cr
- Status
- Added
- Weight
- 6.09%
- Δ weight
- up 1.06 pts
- Value
- ₹168 Cr
- Δ value
- up ₹43.1 Cr
- Status
- Added
- Weight
- 5.09%
- Δ weight
- down 0.28 pts
- Value
- ₹140 Cr
- Δ value
- up ₹7.2 Cr
- Status
- Added
- Weight
- 4.47%
- Δ weight
- down 0.18 pts
- Value
- ₹123 Cr
- Δ value
- up ₹8 Cr
- Status
- Added
- Weight
- 3.72%
- Δ weight
- down 0.18 pts
- Value
- ₹102 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Weight
- 3.71%
- Δ weight
- down 0.78 pts
- Value
- ₹102 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 3.32%
- Δ weight
- up 1.38 pts
- Value
- ₹91.6 Cr
- Δ value
- up ₹43.4 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- down 0.21 pts
- Value
- ₹83.3 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 2.92%
- Δ weight
- down 0.15 pts
- Value
- ₹80.6 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 2.71%
- Δ weight
- down 0.15 pts
- Value
- ₹74.7 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 2.67%
- Δ weight
- down 0.07 pts
- Value
- ₹73.5 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 2.54%
- Δ weight
- down 0.27 pts
- Value
- ₹69.9 Cr
- Δ value
- up ₹21 L
- Status
- Held
- Weight
- 1.95%
- Δ weight
- up 0.11 pts
- Value
- ₹53.8 Cr
- Δ value
- up ₹8.2 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- up 0.02 pts
- Value
- ₹48.5 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 1.57%
- Δ weight
- up 1.10 pts
- Value
- ₹43.2 Cr
- Δ value
- up ₹31.7 Cr
- Status
- Added
- Weight
- 1.52%
- Δ weight
- down 0.06 pts
- Value
- ₹41.8 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 1.37%
- Δ weight
- down 0.14 pts
- Value
- ₹37.6 Cr
- Δ value
- up ₹42 L
- Status
- Added
- Weight
- 1.36%
- Δ weight
- down 0.09 pts
- Value
- ₹37.4 Cr
- Δ value
- up ₹1.5 Cr
- Status
- Added
- Weight
- 1.02%
- Δ weight
- down 0.09 pts
- Value
- ₹28 Cr
- Δ value
- up ₹63 L
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.87%
- Δ weight
- up <0.01 pts
- Value
- ₹23.9 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 0.77%
- Δ weight
- up 0.04 pts
- Value
- ₹21.2 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 0.72%
- Δ weight
- down 2.21 pts
- Value
- ₹19.8 Cr
- Δ value
- down ₹52.9 Cr
- Status
- Trimmed
- Weight
- 0.65%
- Δ weight
- up 0.65 pts
- Value
- ₹17.9 Cr
- Δ value
- up ₹17.9 Cr
- Status
- New
- Weight
- 0.47%
- Δ weight
- down 0.05 pts
- Value
- ₹13.1 Cr
- Δ value
- down ₹5 L
- Status
- Held
- Weight
- 0.47%
- Δ weight
- down 0.04 pts
- Value
- ₹12.9 Cr
- Δ value
- up ₹37 L
- Status
- Added
- Weight
- 0.07%
- Δ weight
- up 0.07 pts
- Value
- ₹2 Cr
- Δ value
- up ₹2 Cr
- Status
- New
- Weight
- 0.04%
- Δ weight
- down <0.01 pts
- Value
- ₹1.1 Cr
- Δ value
- up ₹0 L
- Status
- Held
What changed, Jun 2024 to Jul 2024
New New positions (2)
- Emcure Pharmaceuticals Limited0.6% · ₹17.9 Cr
- Thyrocare Technologies Limited0.1% · ₹2 Cr
Exited Exited (0)
None.
Added Biggest additions
- Suven Pharmaceuticals Limitedup ₹55.9 Cr (+1.09% pts)
- Alembic Pharmaceuticals Limitedup ₹43.1 Cr (+1.06% pts)
- Lupin Limitedup ₹31.7 Cr (+0.43% pts)
- Pfizer Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.8 pts), and fell most in Healthcare Equipment & Supplies (−0.5 pts) and Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology68.8% → 69.7%+0.8 pts
- Healthcare Equipment & Supplies8.4% → 8.0%−0.5 pts
- Healthcare Services14.8% → 14.6%−0.2 pts
- Pharmaceuticals5.6% → 5.4%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2021 | Jul 2023 | Jan 2024 | Apr 2024 | Jun 2024 | Jul 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 60.8% | 72.4% | 71.1% | 71.6% | 68.8% | 69.7% |
| Healthcare Services | 23.3% | 12.8% | 13.3% | 14.0% | 14.8% | 14.6% |
| Healthcare Equipment & Supplies | 6.2% | 5.7% | 7.3% | 6.5% | 8.4% | 8.0% |
| Pharmaceuticals | 7.2% | 5.6% | 6.0% | 5.5% | 5.6% | 5.4% |
| Insurance | 2.5% | 2.3% | 1.7% | 1.8% | 1.8% | 1.8% |
| Retailing | — | 1.3% | 0.6% | 0.6% | 0.5% | 0.5% |
Allocation in Jul 2024change vs Jun 2024
- Pharmaceuticals & Biotechnology (14)69.7%▲ 0.8 pts
- Healthcare Services (8)14.6%▼ 0.2 pts
- Healthcare Equipment & Supplies (2)8.0%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2024
3.3%
▲ 1.4 pts vs Jun 2024
- Cash alone
- 3.3%
- cash and net receivables
- A year earlier
- 2.9%
- Jul 2023 · now ▲ 0.5 pts
- Last 12 months
- 0.9% – 3.3%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.